Literature DB >> 34987262

Health Care Professionals' Perceptions of the Role of the Clinical Pharmacist and Expanded Pharmacist Coverage in Critical Care.

Kristin Kaupp1, Emma K Reid2, Hannah Corney3, Sarah Burgess4, Lauren Hutton5.   

Abstract

BACKGROUND: During the first wave of the COVID-19 pandemic, coverage by critical care pharmacists (CCPs) was expanded in 2 medical-surgical intensive care units at the Queen Elizabeth II Health Sciences Centre, in Halifax, Nova Scotia, from 8 hours per day, 5 days per week, excluding holidays, to 8 hours per day, 7 days per week, including holidays.
OBJECTIVES: To describe health care professionals' opinions about and perceived impacts of the expanded CCP coverage on patient care, as well as their opinions about the role of the CCP as a member of the critical care team.
METHODS: An electronic 22-item survey was distributed to critical care health care professionals to capture opinions and perceived impacts of expanded CCP coverage. The perceived importance of 25 evidence-informed CCP activities was assessed using a 5-point Likert scale.
RESULTS: Thirty-eight complete responses were included (15% response rate, based on distribution of the survey to 249 health care professionals). Most respondents agreed or strongly agreed with the following statements: CCPs are integral members of the critical care team (34/38 [89%]), CCPs play an important role in improving patient outcomes (34/38 [89%]), the presence of CCPs on the unit and on patient care rounds allows other health care professionals to concentrate on their own professional responsibilities (33/38 [87%]), and the expanded CCP coverage improved patient care (29/35 [83%]). Respondents most frequently categorized 23 of the 25 CCP activities as very important.
CONCLUSIONS: Expanded CCP coverage was perceived to have a positive effect on both patient care and members of the critical care team. Most CCP activities were perceived as very important. Given the findings of this quality project, novel staffing models are being explored to optimize CCP coverage. 2022 Canadian Society of Hospital Pharmacists. All content in the Canadian Journal of Hospital Pharmacy is copyrighted by the Canadian Society of Hospital Pharmacy. In submitting their manuscripts, the authors transfer, assign, and otherwise convey all copyright ownership to CSHP.

Entities:  

Keywords:  couverture élargie des pharmaciens; critical care; expanded pharmacist coverage; pharmacy practice; pratique pharmaceutique; soins intensifs

Year:  2022        PMID: 34987262      PMCID: PMC8677002          DOI: 10.4212/cjhp.v75i1.3134

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  8 in total

1.  Impact on Patient Outcomes of Pharmacist Participation in Multidisciplinary Critical Care Teams: A Systematic Review and Meta-Analysis.

Authors:  Heeyoung Lee; Kyungwoo Ryu; Youmin Sohn; Jungmi Kim; Gee Young Suh; EunYoung Kim
Journal:  Crit Care Med       Date:  2019-09       Impact factor: 7.598

2.  The Bedside Critical Care Pharmacist: A Mandatory ICU Team Member Essential for Patient Care.

Authors:  Robert MacLaren; John W Devlin
Journal:  Crit Care Med       Date:  2019-09       Impact factor: 7.598

3.  Health Care Professionals' Opinions and Expectations of Clinical Pharmacy Services on a Surgical Ward.

Authors:  Bernadette Chevalier; Heather L Neville; Kara Thompson; Lisa Nodwell; Michael MacNeil
Journal:  Can J Hosp Pharm       Date:  2016-12-23

4.  A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs.

Authors:  Pamela L Smithburger; Mitchell S Buckley; Mark A Culver; Sarah Sokol; Ishaq Lat; Steven M Handler; Levent Kirisci; Sandra L Kane-Gill
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

5.  Position Paper on Critical Care Pharmacy Services: 2020 Update.

Authors:  Ishaq Lat; Christopher Paciullo; Mitchell J Daley; Robert MacLaren; Scott Bolesta; Jennifer McCann; Joanna L Stollings; Kendall Gross; Sarah A Foos; Russel J Roberts; Nicole M Acquisto; Scott Taylor; Michael Bentley; Judith Jacobi; Tricia A Meyer
Journal:  Crit Care Med       Date:  2020-09       Impact factor: 7.598

6.  The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care.

Authors:  Jeffrey M Rothschild; Christopher P Landrigan; John W Cronin; Rainu Kaushal; Steven W Lockley; Elisabeth Burdick; Peter H Stone; Craig M Lilly; Joel T Katz; Charles A Czeisler; David W Bates
Journal:  Crit Care Med       Date:  2005-08       Impact factor: 7.598

7.  Clinical Practice Guideline: Safe Medication Use in the ICU.

Authors:  Sandra L Kane-Gill; Joseph F Dasta; Mitchell S Buckley; Sandeep Devabhakthuni; Michael Liu; Henry Cohen; Elisabeth L George; Anne S Pohlman; Swati Agarwal; Elizabeth A Henneman; Sharon M Bejian; Sean M Berenholtz; Jodie L Pepin; Mathew C Scanlon; Brian S Smith
Journal:  Crit Care Med       Date:  2017-09       Impact factor: 7.598

Review 8.  Guidelines on critical care services and personnel: Recommendations based on a system of categorization of three levels of care.

Authors:  Marilyn T Haupt; Carolyn E Bekes; Richard J Brilli; Linda C Carl; Anthony W Gray; Michael S Jastremski; Douglas F Naylor; Maria Rudis PharmD; Antoinette Spevetz Md; Suzanne K Wedel; Mathilda Horst Md
Journal:  Crit Care Med       Date:  2003-11       Impact factor: 7.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.